PMOS / PCOS Pathophysiology

Pathophysiology of polycystic ovarian disease: new insights

Insler V, Lunenfeld B

Published September 1991 Human Reproduction (Oxford, England), 6(8), 1025-1029
DOI 10.1093/oxfordjournals.humrep.a137478 PMID 1806558

RRM Academy Synopsis

PCOS may start in the adrenals, brain, ovary or fat tissue

A 1991 review of the research proposes that polycystic ovarian disease (PCOD, now PCOS) can begin in the adrenals, the brain, the ovary or fat tissue. The authors weigh older data against newer findings on insulin and growth factors, and they urge a search for predisposing factors in early life.

Key Findings

  • Reported rates of polycystic ovarian disease (PCOD) range widely, from 0.6 to 92%, because studies use different parameters.
  • The authors call PCOD a multifactorial disease with three clinical features: hyperandrogenism, abnormal luteinizing hormone pulsatility pattern and ovulation disturbances.
  • The chain of events may start in the adrenals, the hypothalamus, higher brain centers or the ovary.
  • Excess fat tissue, usually with hyperinsulinism, or a net rise in active growth factors, may also trigger it.
  • The authors urge early checks for predisposing factors (maternal gestational diabetes, childhood obesity, borderline adrenal hyperplasia, late menarche) to prevent increased risk of later infertility, endometrial and breast cancer, and cardiovascular disease.

Interpretation

The source is the published abstract of a 1991 review article, and the full text was unavailable for this synopsis. The authors assembled their hypothesis from earlier research, recent work on insulin and growth factors, and experiments in neuroendocrinology. The abstract presents a model of how the disease develops. The authors state that each disturbance probably appears early in life, well before clinical signs are evident.

RRM Context

PCOS now has the official name PMOS (Polyendocrine Metabolic Ovarian Syndrome), adopted in May 2026. The authors use the older term PCOD. A model with several possible origins matches the principle of Restorative Reproductive Medicine: find the root cause in each person and evaluate before treating. The focus on early life fits a view across the whole lifespan.

Abstract

The incidence of polycystic ovarian disease (PCOD) varies from 0.6 to 92%, depending on the parameters analysed, PCOD has been reported to appear in association with Cushing's Syndrome, adrenal hyperplasia, hypothyroidism, adrenal and ovarian tumours and some genetic abnormalities. The controversy regarding the pathophysiological mechanism underlying the disease still persists. Critical evaluation of old data, assessment of new findings concerning the possible role of insulin, growth factors and their binding proteins, and extrapolation of neuroendocrinological experiments enabled the construction of a concise hypothesis of the pathophysiology of PCOD. According to this hypothesis, PCOD is a multifactorial disease. The sequence of events finally leading to clinical manifestation of the disease (hyperandrogenism, abnormal luteinizing hormone pulsatility pattern and ovulation disturbances) may originate in different organs or be triggered by different mechanisms. It may stem from the adrenals, the hypothalamus or higher central nervous system centres, or from the ovary itself; it may originate from excess of fat tissue usually combined with hyperinsulinism; or may be the result of a net increase in active growth factors. Each of the above disturbances probably appears early in life, much before the clinical signs of the disease are evident. Predisposing factors such as gestational diabetes of the mother, childhood obesity, borderline adrenal hyperplasia and late menarche have to be looked for as early as possible in order to prevent the late consequences of the disease, such as increased risk of infertility, endometrial and breast cancer and cardiovascular disease.

Read the guide

  • PMOS / PCOS: Causes, Diagnosis, and Treatment

    PMOS / PCOS has four diagnostic phenotypes and distinct metabolic, reproductive, and mental health implications. How RRM-trained clinicians approach diagnosis and treatment differently.

    20 min read

Topics

By this author

Related research

PMOS / PCOS › Pathophysiology › Hyperandrogenism · Reproductive Endocrinology › Ovarian Hormones › Androgens · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
Vaclav Insler, Bruno Lunenfeld
V Insler, B Lunenfeld
PMID 1806558 1806558 DOI 10.1093/oxfordjournals.humrep.a137478 10.1093/oxfordjournals.humrep.a137478 Insler et al. 1991, Insler 1991